CDC42 and neoplasm: Importantly, the expression of a constitutively active form of Cdc42 in mouse fibrosarcoma and human colorectal cancer cells was sufficient to induce resistance against CTLs and NK cell cytotoxicity in vitro, and promoted tumor growth in different mouse models, while it did not affect cell proliferation in vitro.